Horne William E 4
4 · H-CYTE, INC. · Filed Apr 29, 2021
Insider Transaction Report
Form 4
H-CYTE, INC.HCYT
Horne William E
DirectorChief Executive Officer
Transactions
- Other
SERIES A PREFERRED STOCK
2020-09-24$0.01/sh+3,655,382$51,175→ 3,655,382 total(indirect: SEE FOOTNOTE)From: 2020-09-24→ COMMON STOCK (3,655,382 underlying) - Other
STOCK PURCHASE WARRANTS
2020-09-24+1,869,667→ 1,869,667 total(indirect: SEE FOOTNOTE)Exercise: $0.01From: 2020-09-24→ COMMON STOCK (1,869,667 underlying)
Footnotes (5)
- [F1]Received upon conversion of variable conversion price notes at closing of Qualified Financing. Conversion price became fixed at such closing. Series A stock is convertible into common stock on a 1:1 basis.
- [F2]Pursuant to a registered rights offering on September 11, 2020, the Company issued 10,966,145 shares of its Series A Preferred Stock and 5,609,002 warrants to Uyona Management II, LLC. The reporting person has 1/3 ownership of Uyona Management II, LLC. While the rights offering expired on September 11, 2020, it was not consummated until September 24, 2020.
- [F3]Redeemable at option of requisite number of holders in specified circumstances.
- [F4]Received in connection with variable conversion price notes. No additional consideration was paid for warrants. Exercise price became fixed at closing of Qualified Financing.
- [F5]Not applicable.